Literature DB >> 18033231

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy.

Marc A Miller1, J Anthony Gomes, Valentin Fuster.   

Abstract

Hypertrophic cardiomyopathy (HCM) is the most common hereditary cardiac condition and the leading cause of sudden cardiac death (SCD) in young adults. Given that SCD can be the first and most devastating clinical expression of HCM, identifying individuals at high risk is paramount. Determining an individual's risk for HCM-related SCD requires a thorough understanding of the recognized risk factors, of which there are seven established or 'major' and five 'possible'. Major risk factors can be identified by thoroughly reviewing a patient's personal medical history and noninvasive cardiovascular testing. The presence of major risk factors identify patients who are at high enough risk of SCD to warrant consideration of an implantable cardioverter-defibrillator; whereas the absence of any major risk factors provides considerable reassurance to both patient and physician. The risk of HCM-related SCD in patients with no major risk factors is, however, not zero. Possible risk factors gain importance in the presence of an isolated major risk factor. Here, we provide a contemporary review of established and possible risk factors for HCM-related SCD. We also examine microvolt T-wave alternans and cardiovascular MRI as emerging risk stratification tools that could further hone our ability to accurately identify the high-risk patient.

Entities:  

Mesh:

Year:  2007        PMID: 18033231     DOI: 10.1038/ncpcardio1057

Source DB:  PubMed          Journal:  Nat Clin Pract Cardiovasc Med        ISSN: 1743-4297


  8 in total

1.  HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011.

Authors:  Mark S Link; Derek V Exner; Mark Anderson; Michael Ackerman; Amin Al-Ahmad; Bradley P Knight; Steven M Markowitz; Elizabeth S Kaufman; David Haines; Samuel J Asirvatham; David J Callans; J Paul Mounsey; Frank Bogun; Sanjiv M Narayan; Andrew D Krahn; Suneet Mittal; Jagmeet Singh; John D Fisher; Sumeet S Chugh
Journal:  Heart Rhythm       Date:  2011-06-14       Impact factor: 6.343

Review 2.  The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.

Authors:  Iacopo Olivotto; Francesca Girolami; Stefano Nistri; Alessandra Rossi; Luigi Rega; Francesca Garbini; Camilla Grifoni; Franco Cecchi; Magdi H Yacoub
Journal:  J Cardiovasc Transl Res       Date:  2009-10-27       Impact factor: 4.132

Review 3.  Evolving anatomic, functional, and molecular imaging in the early detection and prognosis of hypertrophic cardiomyopathy.

Authors:  Valentin Fuster; Sarina van der Zee; Marc A Miller
Journal:  J Cardiovasc Transl Res       Date:  2009-10-16       Impact factor: 4.132

4.  Arrhythmic sudden death survival prediction using deep learning analysis of scarring in the heart.

Authors:  Dan M Popescu; Julie K Shade; Changxin Lai; Konstantinos N Aronis; David Ouyang; M Vinayaga Moorthy; Nancy R Cook; Daniel C Lee; Alan Kadish; Christine M Albert; Katherine C Wu; Mauro Maggioni; Natalia A Trayanova
Journal:  Nat Cardiovasc Res       Date:  2022-04-07

5.  Therapeutic options in hypertrophic cardiomyopathy: a pediatric perspective.

Authors:  Edward K Rhee; John J Nigro; Stephen G Pophal
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

6.  Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.

Authors:  J T Vehmeijer; I Christiaans; I M van Langen; E Birnie; G J Bonsel; E M A Smets; A A M Wilde
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

7.  Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress.

Authors:  Norishige Morita; Ali A Sovari; Yuanfang Xie; Michael C Fishbein; William J Mandel; Alan Garfinkel; Shien-Fong Lin; Peng-Sheng Chen; Lai-Hua Xie; Fuhua Chen; Zhilin Qu; James N Weiss; Hrayr S Karagueuzian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

8.  Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

Authors:  Thomas Force; Robert O Bonow; Steven R Houser; R John Solaro; Ray E Hershberger; Bishow Adhikari; Mark E Anderson; Robin Boineau; Barry J Byrne; Thomas P Cappola; Raghu Kalluri; Martin M LeWinter; Martin S Maron; Jeffery D Molkentin; Steve R Ommen; Michael Regnier; W H Wilson Tang; Rong Tian; Marvin A Konstam; Barry J Maron; Christine E Seidman
Journal:  Circulation       Date:  2010-09-14       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.